Search alternatives:
increase decrease » increased release (Expand Search), increased crash (Expand Search)
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
larger decrease » marked decrease (Expand Search)
increase decrease » increased release (Expand Search), increased crash (Expand Search)
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
larger decrease » marked decrease (Expand Search)
-
1241
-
1242
Results for the asymmetric relationship between military expenditures and DOD energy consumption.
Published 2025Subjects: -
1243
-
1244
Summary of study eligibility criteria.
Published 2025“…Considering the high prevalence of BV among African, Caribbean and Black (ACB) women, we conducted a prospective, randomized, open-label phase 1 clinical trial to determine the feasibility, safety and tolerability of administering low-dose estrogen, probiotics or both in combination to improve vaginal health and decrease HIV-1 susceptibility.</p><p>Methods</p><p>ACB women aged 18–49 from the Greater Toronto Area (GTA) were randomized to one of four study arms: intravaginal estradiol (Estring©; 7.5mg/day); a vaginal probiotic (RepHresh™ Pro-B™) administered twice daily; a combination of Estring© and vaginal RepHresh™ Pro-B™ (twice daily); or the Estring© and oral RepHresh™ Pro-B™ (twice daily), for a duration of 30 days. …”
-
1245
Summary of study participation and feasibility.
Published 2025“…Considering the high prevalence of BV among African, Caribbean and Black (ACB) women, we conducted a prospective, randomized, open-label phase 1 clinical trial to determine the feasibility, safety and tolerability of administering low-dose estrogen, probiotics or both in combination to improve vaginal health and decrease HIV-1 susceptibility.</p><p>Methods</p><p>ACB women aged 18–49 from the Greater Toronto Area (GTA) were randomized to one of four study arms: intravaginal estradiol (Estring©; 7.5mg/day); a vaginal probiotic (RepHresh™ Pro-B™) administered twice daily; a combination of Estring© and vaginal RepHresh™ Pro-B™ (twice daily); or the Estring© and oral RepHresh™ Pro-B™ (twice daily), for a duration of 30 days. …”
-
1246
NPF-NPFR pathway in LNd-LPN feedback circuit fine-tune cooling induced locomotion increase.
Published 2024“…(C, D) Optogenetic activation of LNds using CsChrimson (<i>DvPdf-Gal4>Uas-CsChrimson</i>, red line) decreases sleep and this decrease effect was enhanced by NPF RNAi (<i>DvPdf-Gal4>Uas-CsChrimson; Uas-NPF RNAi</i>; green line). …”
-
1247
Results obtained from different regression models along with their respective AIC values.
Published 2025Subjects: -
1248
Descriptive statistics for the number of under five children death per 100 mothers.
Published 2025Subjects: -
1249
-
1250
-
1251
-
1252
-
1253
-
1254
-
1255
-
1256
-
1257
-
1258
-
1259
-
1260